Top Markets
#1 Helium Helium +59.21%
#2 GEKKO GEKKO +52.86%
#3 TENDIES TENDIES +41.58%
#4 ADO Protocol ADO Protocol +38.93%
#5 Pons Pons +36.07%
#6 StonkBroker StonkBroker +31.45%
#7 Collector Crypt Collector Crypt +30.65%
#8 Prom Prom +28.68%
#9 o1.exchange o1.exchange +22.50%
#10 龙虾 (Lobster) 龙虾 (Lobster) +20.71%
Coin of the day
Helium Helium
Setări
Limbă
ROMâNă
Monedă
USD
Temă
CARsgen Therapeutics Holdings Limited CARsgen Therapeutics Holdings Limited

CARsgen Therapeutics Holdings Limited

2171
Rang în acțiuni #9600
CARsgen Therapeutics Holdings Limited, a biopharmaceutical firm founded in... CARsgen Therapeutics Holdings Limited, a biopharmaceutical firm founded in Shanghai, China, in 2014, focuses on the discovery, development, and commercialization of advanced chimeric antigen receptor T (CAR-T) cell therapies. The company's efforts are directed toward treating various hematological malignancies and solid tumors across China and the United States. Its robust pipeline includes several key candidates: CT053, an autologous CAR-T product, is currently in a pivotal Phase II trial in China for relapsed/refractory multiple myeloma. Additionally, CT041, another autologous CAR-T, is undergoing Phase Ib/II clinical trials for advanced gastric/gastroesophageal junction and pancreatic cancers in China, and Phase Ib trials for comparable indications in the U.S. CARsgen is also advancing CT011, an autologous CAR-T candidate, through Phase I for patients with Glypican-3 positive advanced hepatocellular carcinoma, and CT032, an autologous CAR-T, in Phase I/II for B cell Non-Hodgkin's lymphoma in China. Furthermore, its pipeline features AB011, a humanized monoclonal antibody in Phase I for CLDN18.2 positive solid tumors in China, as well as CT017, an autologous Glypican-3-targeted CAR-T for hepatocellular carcinoma, and other promising therapies for solid tumors.
Preț acțiune
$1.72
Ultima sincronizare: 2026-08-28
Capitalizare de piață
$981.92M
Schimbare (1 zi)
-1.68%
Schimbare (1 an)
-41.83%
Țară
CN
Tranzacționează CARsgen Therapeutics Holdings Limited (2171)

Categorie

Healthcare
Istoric dividende pentru CARsgen Therapeutics Holdings Limited (2171)
CARsgen Therapeutics Holdings Limited (simbol acțiune: 2171) a efectuat un total de 0 plăți de dividende.
Suma tuturor dividendelor (ajustată pentru split-uri de acțiuni) este: 0.00
Randamentul dividendului (TTM): 0
Plăți de dividende pentru CARsgen Therapeutics Holdings Limited (2171) din 2026 până în 2026
Plăți anuale de dividende
An Dividend (ajustat pentru split de acțiuni) Schimbă
Nu sunt suficiente date pentru perioada selectată.
Lista tuturor plăților de dividende
An Dividend Schimbă
Nu sunt suficiente date pentru perioada selectată.
Dividende ale companiilor similare sau concurente
Companie Număr de plăți de dividende Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH